Versant Capital Management
ACAD icon

Versant Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Versant Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.6K Buy
974
+38
+4% +$1.02K ﹤0.01% 1969
2026
Q2 		$23.7K Buy
936
+328
+54% +$7.22K ﹤0.01% 1851
2026
Q1 		$13.5K Buy
608
+72
+13% +$1.72K ﹤0.01% 2004
2025
Q4 		$14.3K Sell
536
-192
-26% -$4.59K ﹤0.01% 1832
2025
Q3 		$15.5K Hold
728
– – ﹤0.01% 1718
2025
Q2 		$15.7K Sell
728
-43
-6% -$799 ﹤0.01% 1658
2025
Q1 		$12.8K Buy
771
+235
+44% +$4.27K ﹤0.01% 1591
2024
Q4 		$9.8K Buy
+536
New +$8.65K ﹤0.01% 1408
2023
Q4 		– Sell
-24
Closed -$500 – 1913
2023
Q3 		$500 Hold
24
– – ﹤0.01% 1693
2023
Q2 		$575 Buy
+24
New +$533 ﹤0.01% 1797
2023
Q1 		– Sell
-49
Closed -$780 – 1767
2022
Q4 		$780 Hold
49
– – ﹤0.01% 1357
2022
Q3 		$1K Buy
+49
New +$794 ﹤0.01% 1169
2021
Q4 		– Sell
-22
Closed – – 1414
2021
Q3 		$0 Sell
22
-114
-84% -$2.2K ﹤0.01% 1427
2021
Q2 		$3K Buy
+136
New +$3.07K ﹤0.01% 1013
2021
Q1 		– Sell
-31
Closed -$1K – 1501
2020
Q4 		$1K Sell
31
-6
-16% -$298 ﹤0.01% 1177
2020
Q3 		$1K Hold
37
– – ﹤0.01% 1136
2020
Q2 		$1K Hold
37
– – ﹤0.01% 1131
2020
Q1 		$1K Buy
+37
New +$1.52K ﹤0.01% 1087

Other funds holding ACAD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Versant Capital Management's ACAD Position: Q3 2026 in Review

Versant Capital Management increased its Acadia Pharmaceuticals (ACAD) stake by 4.1% in Q3 2026, buying an estimated $1.02K and bringing the position to 974 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1969.

Versant Capital Management first reported a position in ACAD in Q1 2020 and has held it in 18 quarters since. The position peaked at $23.7K in Q2 2026. 179 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • Versant Capital Management held 974 shares of Acadia Pharmaceuticals worth $19.6K as of Q3 2026.
  • Versant Capital Management bought 38 Acadia Pharmaceuticals shares in Q3 2026, an estimated $1.02K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1969 holding.
  • Versant Capital Management first reported a position in Acadia Pharmaceuticals in Q1 2020 and has held it in 18 quarters since.
  • Versant Capital Management's Acadia Pharmaceuticals position peaked at $23.7K in Q2 2026.
  • 179 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.